Dopamine agonists and levodopa are commonly used dopaminergic medications to treat Parkinson's disease. However, they act differently on the dopamine system in the brain and may therefore each affect cognition in a unique way. We study patients with Parkinson's disease on and off their medication to investigate the unique contributions of levodopa and dopamine agonists on action control, risk-taking and reward learning.